140 related articles for article (PubMed ID: 24905771)
1. The study of severe cutaneous drug hypersensitivity reactions from a systems biology perspective.
Perkins JR; Ayuso P; Cornejo-García JA; Ranea JA
Curr Opin Allergy Clin Immunol; 2014 Aug; 14(4):301-6. PubMed ID: 24905771
[TBL] [Abstract][Full Text] [Related]
2. Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome.
Ko TM; Chung WH; Wei CY; Shih HY; Chen JK; Lin CH; Chen YT; Hung SI
J Allergy Clin Immunol; 2011 Dec; 128(6):1266-1276.e11. PubMed ID: 21924464
[TBL] [Abstract][Full Text] [Related]
3. T-cell receptor and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: understanding a hypersensitivity reaction.
Ko TM; Chen YT
Expert Rev Clin Immunol; 2012 Jul; 8(5):467-77. PubMed ID: 22882221
[TBL] [Abstract][Full Text] [Related]
4. Human leukocyte antigens and drug hypersensitivity.
Chung WH; Hung SI; Chen YT
Curr Opin Allergy Clin Immunol; 2007 Aug; 7(4):317-23. PubMed ID: 17620823
[TBL] [Abstract][Full Text] [Related]
5. Toxic epidermal necrolysis: the year in review.
Lee HY; Chung WH
Curr Opin Allergy Clin Immunol; 2013 Aug; 13(4):330-6. PubMed ID: 23799330
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in the genetics and immunology of Stevens-Johnson syndrome and toxic epidermal necrosis.
Chung WH; Hung SI
J Dermatol Sci; 2012 Jun; 66(3):190-6. PubMed ID: 22541332
[TBL] [Abstract][Full Text] [Related]
7. New approaches for predicting T cell-mediated drug reactions: A role for inducible and potentially preventable autoimmunity.
Michels AW; Ostrov DA
J Allergy Clin Immunol; 2015 Aug; 136(2):252-7. PubMed ID: 26254052
[TBL] [Abstract][Full Text] [Related]
8. New genetic findings lead the way to a better understanding of fundamental mechanisms of drug hypersensitivity.
Pirmohamed M; Ostrov DA; Park BK
J Allergy Clin Immunol; 2015 Aug; 136(2):236-44. PubMed ID: 26254050
[TBL] [Abstract][Full Text] [Related]
9. Immunogenetics of drug-induced skin blistering disorders. Part I: Perspective.
Bowman C; Delrieu O
Pharmacogenomics; 2009 Apr; 10(4):601-21. PubMed ID: 19374517
[TBL] [Abstract][Full Text] [Related]
10. T cell-mediated hypersensitivity reactions to drugs.
Pavlos R; Mallal S; Ostrov D; Buus S; Metushi I; Peters B; Phillips E
Annu Rev Med; 2015; 66():439-54. PubMed ID: 25386935
[TBL] [Abstract][Full Text] [Related]
11. Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations.
Hsiao YH; Hui RC; Wu T; Chang WC; Hsih MS; Yang CH; Ho HC; Chang YG; Chen MJ; Lin JY; Chen DP; Chang PY; Wu TL; Hung SI; Chung WH
J Dermatol Sci; 2014 Feb; 73(2):101-9. PubMed ID: 24268988
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacogenomics of severe drug hypersensitivity reactions--from bench to bedside].
Porębski G; Dyga W; Stobiecki M; Czarnobilska E
Przegl Lek; 2015; 72(12):779-82. PubMed ID: 27024960
[TBL] [Abstract][Full Text] [Related]
13. Genetic markers and danger signals in stevens-johnson syndrome and toxic epidermal necrolysis.
Chung WH; Hung SI
Allergol Int; 2010 Dec; 59(4):325-32. PubMed ID: 20962567
[TBL] [Abstract][Full Text] [Related]
14. HLA and pharmacogenetics of drug hypersensitivity.
Pavlos R; Mallal S; Phillips E
Pharmacogenomics; 2012 Aug; 13(11):1285-306. PubMed ID: 22920398
[TBL] [Abstract][Full Text] [Related]
15. HLA and Delayed Drug-Induced Hypersensitivity.
Sousa-Pinto B; Correia C; Gomes L; Gil-Mata S; Araújo L; Correia O; Delgado L
Int Arch Allergy Immunol; 2016; 170(3):163-79. PubMed ID: 27576480
[TBL] [Abstract][Full Text] [Related]
16. Differential gene expression in drug hypersensitivity reactions: induction of alarmins in severe bullous diseases.
Bellón T; Alvarez L; Mayorga C; Morel E; Torres MJ; Martín-Díaz MA; Díaz R; Radial A; Carballo M; Blanca M
Br J Dermatol; 2010 May; 162(5):1014-22. PubMed ID: 20030638
[TBL] [Abstract][Full Text] [Related]
17. Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome.
Wei CY; Chung WH; Huang HW; Chen YT; Hung SI
J Allergy Clin Immunol; 2012 Jun; 129(6):1562-9.e5. PubMed ID: 22322005
[TBL] [Abstract][Full Text] [Related]
18. HLA-B*5801: utility and cost-effectiveness in the Asia-Pacific Region.
Yeo SI
Int J Rheum Dis; 2013 Jun; 16(3):254-7. PubMed ID: 23981744
[TBL] [Abstract][Full Text] [Related]
19. HLA alleles and drug hypersensitivity reactions.
Profaizer T; Eckels D
Int J Immunogenet; 2012 Apr; 39(2):99-105. PubMed ID: 22136512
[TBL] [Abstract][Full Text] [Related]
20. Drug-induced epidermal necrolysis: Important new piece to end the puzzle.
Roujeau JC; Bricard G; Nicolas JF
J Allergy Clin Immunol; 2011 Dec; 128(6):1277-8. PubMed ID: 22133320
[No Abstract] [Full Text] [Related]
[Next] [New Search]
